NCT04081883View on ClinicalTrials.gov

Biosensors for Open and Closed-loop Glycemia Control in T1D Patients With Insulin Pump

NACompletedINTERVENTIONAL
Enrollment

1

Participants

Timeline

Start Date

January 27, 2023

Primary Completion Date

January 27, 2024

Study Completion Date

January 27, 2024

Conditions
Diabetes Mellitus, Type 1
Interventions
OTHER

Biosensor algorithm

The biosensor DIABLO responses will be compared to the measurements of standard CGMS, using blood glucose measures every 10 minutes by taking interstitial fluid from Diabetes Type 1 (DT1) patients with an internal or external insulin pump.

Trial Locations (1)

33000

Hôpital Saint-André, Bordeaux

All Listed Sponsors
lead

University Hospital, Bordeaux

OTHER